Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.

Moshfeghi D, Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K.

Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):750-3.

PMID:
10574497
2.

Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).

Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.

Ophthalmology. 1999 Jul;106(7):1384-91.

PMID:
10406627
3.

Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.

Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.

Retina. 2001;21(5):499-508.

PMID:
11642380
4.

Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.

Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I.

Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):323-7.

PMID:
10928670
5.

Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation.

Sheyhedin I, Okunaka T, Kato H, Yamamoto Y, Sakaniwa N, Konaka C, Aizawa K.

Lasers Surg Med. 2000;26(1):83-9.

PMID:
10637007
6.

Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model.

Mori K, Kanai K, Peyman GA, Yoneya S.

Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):142-7.

PMID:
17396695
7.

Threshold power levels for NPe6 photodynamic therapy.

Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.

Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42.

PMID:
10743925
8.

Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.

Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.

Retina. 2001;21(5):493-8.

PMID:
11642379
9.

Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.

Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.

Anticancer Res. 2003 Nov-Dec;23(6C):4897-900.

PMID:
14981942
10.

Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.

Wong TW, Aizawa K, Sheyhedin I, Wushur C, Kato H.

J Pharmacol Sci. 2003 Oct;93(2):136-42.

11.
12.

[Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].

Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.

Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):134-40. Japanese.

PMID:
9124093
13.

Problems with and pitfalls of photodynamic therapy.

Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM.

Ophthalmology. 2000 Jan;107(1):29-35.

PMID:
10647715
14.

Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.

Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.

Lasers Surg Med. 2001;28(4):381-8.

PMID:
11344521
15.

Improved leukocyte tracking in mouse retinal and choroidal circulation.

Xu H, Manivannan A, Goatman KA, Liversidge J, Sharp PF, Forrester JV, Crane IJ.

Exp Eye Res. 2002 Mar;74(3):403-10.

PMID:
12014921
16.

Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6.

Hayashi J, Kuroiwa Y, Sato H, Saito T, Aizawa K.

Cardiovasc Res. 1993 Nov;27(11):1943-7.

PMID:
8287401
17.

A new fluorescent imaging procedure in vivo for evaluation of the retinal microcirculation in rats.

Kimura H, Kiryu J, Nishiwaki H, Ogura Y.

Curr Eye Res. 1995 Mar;14(3):223-8.

PMID:
7796605
18.

Evaluation of leukocyte dynamics in choroidal circulation with indocyanine green-stained leukocytes.

Takasu I, Shiraga F, Okanouchi T, Tsuchida Y, Ohtsuki H.

Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2844-8.

PMID:
10967036
19.

Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6.

Li L, Kodama K, Saito K, Aizawa K.

J Photochem Photobiol B. 2002 May;67(1):51-6.

PMID:
12007467
20.

Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.

Kanai M, Obana A, Gohto Y, Nagata S, Miki T, Kaneda K, Nakajima S.

Lasers Surg Med. 2000;26(1):48-57.

PMID:
10637003

Supplemental Content

Support Center